Two markers of cerebral small vessel disease are white matter hyperintensities and cerebral microbleeds, which commonly occur in people with Alzheimer's disease.
Aim and/or hypothesis
To test for independent associations between two Alzheimer's disease-susceptibility gene loci – APOE ε and the TOMM40 ‘523’ poly-T repeat – and white matter hyperintensities/cerebral microbleed burden in community-dwelling older adults.
Methods
Participants in the Lothian Birth Cohort 1936 underwent genotyping for APOE ε and TOMM40 523, and detailed structural brain magnetic resonance imaging at a mean age of 72·70 years (standard deviation = 0·7; range = 71–74).
Results
No significant effects of APOE ε or TOMM40 523 genotypes on white matter hyperintensities or cerebral microbleed burden were found amongst 624 participants.
Conclusions
Lack of association between two Alzheimer's disease susceptibility gene loci and markers of cerebral small vessel disease may reflect the relative health of this population compared with those in other studies in the literature.
StampferMJ. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med2006; 260:211–23.
2.
WardlawJMSmithEEBiesselsGJ. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol2013; 12:822–38.
3.
BrickmanAMSiedleckiKLMuraskinJ. White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiol Aging2011; 32:1588–98.
4.
RosesADLutzMWCrenshawDGGrossmanISaundersAMGottschalkWK. TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial. Alzheimers Dement2013; 9:132–6.
5.
PaternosterLChenWSudlowCLM. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke2009; 40:2020–6.
6.
SchillingSDeStefanoALSachdevPS. APOE genotype and MRI markers of cerebrovascular disease. Neurology2013; 81:292–300.
7.
MaxwellSSJacksonCAPaternosterL. Genetic associations with brain microbleeds Systematic review and meta-analyses. Neurology2011; 77:158–67.
8.
RomeroJRPreisSRBeiserA. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke2014; 45:1492–4.
9.
CaselliRJDueckACHuentelmanMJ. Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement2012; 8:490–5.
10.
LutzMWCrenshawDGSaundersAMRosesAD. Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement2010; 6:125–31.
11.
RosesAD. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol2010; 67:536–41.
12.
DearyIJGowAJTaylorMD. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr2007; 7:28.
13.
WardlawJMBastinMEValdés HernándezMC. Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke2011; 6:547–59.
14.
DearyIJGowAJPattieAStarrJM. Cohort profile: the Lothian birth cohorts of 1921 and 1936. Int J Epidemiol2012; 41:1576–84.
15.
LinnertzCSaundersAMLutzMW. Characterization of the poly-t variant in the tomm40 gene in diverse populations. PLoS ONE2012; 7:e30994.
16.
Valdés HernándezMDCFergusonKJChappellFMWardlawJM. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol2010; 20:1684–91.
17.
CordonnierCPotterGMJacksonCA. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke2009; 40:94–9.
18.
BrunoDNierenbergJJRitchieJCLutzMWPomaraN. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. Psychoneuroendocrinology2012; 37:366–71.
19.
FolsteinMFFolsteinSEMcHughPR. Mini-Mental State: a practical method for grading the state of patients for the clinician. J Psychiatr Res1975; 12:189–98.
20.
TombaughTNMcIntyreNJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc1992; 40:922–35.
21.
SveinbjornsdottirSSigurdssonSAspelundT. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry2008; 79:1002–6.
22.
JeerakathilTWolfPABeiserA. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke2004; 35:1831–5.
23.
HoferSMSliwinskiMJ. Understanding ageing: an evaluation of research designs for assessing the interdependence of ageing-related changes. Gerontology2001; 47:341–52.
24.
LyallDMLopezLMBastinME. ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936. Behav Genet2013; 43:13–23.
25.
RosvallLRizzutoDWangHXWinbladBGraffCFratiglioniL. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging2009; 30:1545–51.
